Zanubrutinib

21/11/2019 20 min
Zanubrutinib

Listen "Zanubrutinib"

Episode Synopsis

BTK-targeting therapy approved again! Zanubrutinib approved for Mantle Cell Lymphoma (2nd line) - how does it compare to ibrutinib and acalabrutinib?